홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.0
  1. 홈
  2. /반응

HCID 86735652, 화합물 → HCID 86735651, 화합물

HRID 2083798
노트
인쇄 미리보기

반응식

HRID 2083798 반응식
[P:1]([O:9][CH2:10][C@H:11]1[O:15][C@@H:14]([N:16]2[CH:38]=[CH:37][C:20]([NH:21][C:22](=[O:36])[CH2:23][CH2:24][CH2:25][CH2:26][CH2:27][CH2:28][CH2:29][CH2:30][CH2:31][CH2:32][CH2:33][CH2:34][CH3:35])=[N:19][C:17]2=[O:18])[C@H:13]([OH:39])[C@@H:12]1[OH:40])([O:4]P(O)(O)=O)(=[O:3])[OH:2].P(OC[C@H]1O[C@@H](N2C=CC(NC(=O)CCCCCCCCCCCCCC)=NC2=O)[C@H](O)[C@@H]1O)(OP(O)(O)=O)(=O)O.P(OC[C@H]1O[C@@H](N2C=CC(NC(=O)CCCCCCCCCCCCCCC)=NC2=O)[C@H](O)[C@@H]1O)(OP(O)(O)=O)(=O)O.P(OC[C@H]1O[C@@H](N2C=CC(NC(=O)CCCCCCCCCCCCCCCC)=NC2=O)[C@H](O)[C@@H]1O)(OP(O)(O)=O)(=O)O.P(OC[C@H]1O[C@@H](N2C=CC(NC(=O)CCCCCCCCCCCCCCCCC)=NC2=O)[C@H](O)[C@@H]1O)(OP(O)(O)=O)(=O)O.P(OC[C@H]1O[C@@H](N2C=CC(NC(=O)CCCCCCCCCCCCCCCCCC)=NC2=O)[C@H](O)[C@@H]1O)(OP(O)(O)=O)(=O)O.P(OC[C@H]1O[C@@H](N2C=CC(NC(=O)CCCCCCCCCCCCCCCCCCC)=NC2=O)[C@H](O)[C@@H]1O)(OP(O)(O)=O)(=O)O.P(OC[C@H]1O[C@@H](N2C=CC(NC(=O)CCCCCCCCCCCCCCCCCCCC)=NC2=O)[C@H](O)[C@@H]1O)(OP(O)(O)=O)(=O)O.P(OC[C@H]1O[C@@H](N2C=CC(NC(=O)CCCCCCCCCCCCCCCCCCCCC)=NC2=O)[C@H](O)[C@@H]1O)(OP(O)(O)=O)(=O)O.P(OC[C@H]1O[C@@H](N2C=CC(NC(=O)CCCCCCC/C=C\CCCCCCCC)=NC2=O)[C@H](O)[C@@H]1O)(OP(O)(O)=O)(=O)O>>[P:1]([O:9][CH2:10][C@H:11]1[O:15][C@@H:14]([N:16]2[CH:38]=[CH:37][C:20]([NH:21][C:22](=[O:36])[CH2:23][CH2:24][CH2:25][CH2:26][CH2:27][CH2:28][CH2:29][CH2:30][CH2:31][CH2:32][CH2:33][CH2:34][CH3:35])=[N:19][C:17]2=[O:18])[C@H:13]([OH:39])[C@@H:12]1[OH:40])([OH:3])([OH:4])=[O:2]
참가 물질실험 절차출처 및 근거반응 노트

참가 물질

11

반응물 10

HCID 86735652HCID 86735652, 화합물HCID 86735653HCID 86735653, 화합물HCID 86735654HCID 86735654, 화합물HCID 86735655HCID 86735655, 화합물HCID 86735656HCID 86735656, 화합물HCID 86735657HCID 86735657, 화합물
HCID 86735658
HCID 86735658, 화합물
HCID 86735659HCID 86735659, 화합물
HCID 86735660HCID 86735660, 화합물
HCID 86735661HCID 86735661, 화합물

생성물 1

HCID 86735651HCID 86735651, 화합물

실험 절차

Also, the following the above procedure using N4 -myristoylcytidine-5'-pyrophosphate, N4 -pentadecanoylcytidine-5'-pyrophosphate, N4 -palmitoylcytidine-5'-pyrophosphate, N4 -margaroylcytidine-5'-pyrophosphate, N4 -stearoylcytidine-5'-pyrophosphate, N4 -nonadecanoylcytidine-5'-pyrophosphate, N4 -arachidoylcytidine-5'-pyrophosphate, N4 -heneicosanoylcytidine-5'-pyrophosphate, N4 -behenoylcytidine-5'-pyrophosphate, and N4 -oleoylcytidine-5'-pyrophosphate, respectively, instead of N4 -myristoylcytidine-5'-phosphate, the following products were obtained:

출처 및 근거

ORD 기록
ord-53f55efa96204047b3ccd75c8901eb85
출처 데이터셋
uspto-grants-1978_04
DOI
10.6084/m9.figshare.5104873.v1
특허 번호
US04086417

반응 노트

불러오는 중…

이 페이지에서참가 물질실험 절차출처 및 근거반응 노트